Biosimilar and Interchangeable Biologics: From Cell Line to Commercial Launch, Two Volume Set

by Sarfaraz K. Niazi

What's the Deal with Biosimilars?

Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. The biological drugs are produced by recombinant DNA technology that allows for large-scale production and an overall reduction time in costs and development.

Biosimilars and Interchangeable Biologics: From Cell Line to Commercial Launch covers...

• Format: Paperback
• Language: English
• ISBN: 1138749745
• ISBN13: 9781138749740
• Release Date: December 2030
• Publisher: CRC Press
• Length: 1174 Pages